Expanded Recall of Hospira Liposyn and Propofol (Sept. 2010)

Hospira is expanding a recall of several of the company's injectable products because some of the containers may contain particulate matter, which consists mainly of inert stainless steel particles that are not visible. Because these particulates do not dissolve in blood, they could potentially act as emboli and impede blood flow or cause mechanical damage to the body.

This recall, which broadens the company's first action on March 31, 2010, affects a number of lots of Hospira's propofol injectable emulsion 1%. It also affects Liposyn products, including Liposyn II in 10 and 20 percent, and Liposyn III in 10, 20 and 30 percent.

Anyone who has propofol or Liposyn from the recalled lots should not use or distribute it further. Quarantine the products immediately and arrange for a return by calling 1-877-884-7835. The company is working with FDA to address the issues that led to the recall, and will distribute new product as it becomes available.

Category:

Science & Technology

Tags:

• Hospira
• FDA
• Injectable
• Liposyn
• Propofol
• Patient Safety
• Injury